Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- May is Huntington’s Disease Awareness Month
- Microgravity Could Be the Key to Developing New Therapies for Neurogenerative Diseases
- Expert Q&A: ‘Invisible’ Stem Cells
- iPS Cell Research Can Give Japan Lead in Regenerative Medicine
- Tiny CRISPR tool opens door to faster, simpler plant genome editing
- This Injected Protein-like Polymer Helps Tissues Heal After a Heart Attack